1. Home
  2. SMHI vs GALT Comparison

SMHI vs GALT Comparison

Compare SMHI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEACOR Marine Holdings Inc.

SMHI

SEACOR Marine Holdings Inc.

HOLD

Current Price

$7.46

Market Cap

188.9M

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.59

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMHI
GALT
Founded
1989
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.9M
199.2M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
SMHI
GALT
Price
$7.46
$2.59
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
140.8K
334.5K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
62.41
N/A
EPS
N/A
N/A
Revenue
$173,783,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.63
$1.15
52 Week High
$8.17
$7.13

Technical Indicators

Market Signals
Indicator
SMHI
GALT
Relative Strength Index (RSI) 52.34 37.48
Support Level $7.18 $2.07
Resistance Level $7.86 $3.32
Average True Range (ATR) 0.40 0.20
MACD -0.00 -0.03
Stochastic Oscillator 61.44 3.85

Price Performance

Historical Comparison
SMHI
GALT

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: